Gastrointestinal Cancer
From the Journals
Third COVID booster benefits cancer patients
For the first time, researchers have quantified the benefits of boosters for COVID-19 in cancer patients.
From the Journals
Chronic hepatitis B infections associated with a range of liver malignancies
Treatment with nucleos(t)ide analogues lowers risk of extrahepatic cancer in patients with hepatitis B infections.
Latest News
Link between PCOS and increased risk of pancreatic cancer?
“These data suggest some individuals may have unknown metabolic derangements that may underlie the development of both conditions.”
From the Journals
Patients at risk for Barrett’s esophagus rarely screened
Adults with GERD and their primary care providers may lack knowledge about recommended screening for Barrett’s esophagus, a new survey shows.
Latest News
Radiotherapy shows benefit in difficult liver cancer cases
SBRT combined with sorafenib led to a strong survival benefit versus sorafenib alone in a difficult to treat liver cancer.
From the Journals
Novel YouTube study detects colonoscopy misinformation, guides better content creation
A cohort study finds more than half of the most viewed social media videos on colonoscopy contain inaccurate or contradictory information.
Conference Coverage
Easier bowel prep recipe yields real-world results
A reduced-volume bowel prep formulation was safe and was associated with high rates of adequate or better cleansing in a large practice-based...
Conference Coverage
Some young CRC patients are missing out on genetic counseling, testing
Genetic counseling and testing of patients under 50 with CRC have improved over the last decade, but about 20% of patients still don’t get...
Conference Coverage
EUS-guided RF ablation doubles survival for unresectable pancreatic cancer
Endoscopic ultrasound–guided radiofrequency ablation of tumors improved overall survival compared with standard of care.
Conference Coverage
Pancreatic cancer screening appears safe, effective for high-risk patients
The study explored a targeted strategy for screening since pancreatic cancer screening is not recommended for the general population.
News
FDA approves new immunotherapy combo for liver cancer